LCSIX vs. CURE

Last updated Jun 13, 2026

LCSIX (LoCorr Long/Short Commodity Strategies Fund) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both funds - LCSIX is a Systematic Trend fund managed by LoCorr Funds, while CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%). Over the past 10 years, LCSIX returned 2.78%/yr vs 13.49%/yr for CURE. At a correlation of -0.03, they often move in opposite directions. LCSIX charges 1.75%/yr vs 1.08%/yr for CURE.

Performance

LCSIX vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in LoCorr Long/Short Commodity Strategies Fund (LCSIX) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LCSIX achieves a 2.32% return, which is significantly higher than CURE's -7.96% return. Over the past 10 years, LCSIX has underperformed CURE with an annualized return of 2.78%, while CURE has yielded a comparatively higher 13.49% annualized return.

LCSIX

• 1D: 0.23%
• 1M: 0.68%
• YTD: 2.32%
• 6M: 1.03%
• 1Y: 0.15%
• 3Y*: -1.68%
• 5Y*: 0.93%
• 10Y*: 2.78%

CURE

• 1D: -0.55%
• 1M: 17.48%
• YTD: -7.96%
• 6M: -6.00%
• 1Y: 28.51%
• 3Y*: 3.05%
• 5Y*: 1.51%
• 10Y*: 13.49%

*Multi-year figures are annualized to reflect compound growth (CAGR)

LCSIX vs. CURE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LCSIX LoCorr Long/Short Commodity Strategies Fund	2.32%	1.13%	-8.29%	-3.07%	6.04%	14.90%	9.90%	-5.97%	15.16%	6.19%
CURE Direxion Daily Healthcare Bull 3x Shares	-7.96%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	2.82%	69.32%

Correlation

The correlation between LCSIX and CURE is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.09
Correlation (3Y) Calculated over the trailing 3-year period	0.06
Correlation (5Y) Calculated over the trailing 5-year period	0.06
Correlation (10Y) Calculated over the trailing 10-year period	-0.01
Correlation (All Time) Calculated using the full available price history since Jan 17, 2012	-0.03

The correlation between LCSIX and CURE shifts across timeframes, from -0.03 (all time) to 0.09 (1 year), reflecting how their relationship changes across market environments.

Return for Risk

LCSIX vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LCSIX

LCSIX Risk / Return Rank: 6
LCSIX Sharpe Ratio Rank: 6
LCSIX Sortino Ratio Rank: 5
LCSIX Omega Ratio Rank: 6
LCSIX Calmar Ratio Rank: 7
LCSIX Martin Ratio Rank: 6

CURE

CURE Risk / Return Rank: 21
CURE Sharpe Ratio Rank: 20
CURE Sortino Ratio Rank: 24
CURE Omega Ratio Rank: 22
CURE Calmar Ratio Rank: 22
CURE Martin Ratio Rank: 19

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LCSIX vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for LoCorr Long/Short Commodity Strategies Fund (LCSIX) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	LCSIX	CURE	Difference
Sharpe ratio: Return per unit of total volatility	0.22	0.60	-0.38
Sortino ratio: Return per unit of downside risk	0.35	1.18	-0.84
Omega ratio: Gain probability vs. loss probability	1.05	1.13	-0.08
Calmar ratio: Return relative to maximum drawdown	0.36	0.85	-0.49
Martin ratio: Return relative to average drawdown	0.68	1.94	-1.26

LCSIX vs. CURE - Sharpe Ratio Comparison

The current LCSIX Sharpe Ratio is 0.22, which is lower than the CURE Sharpe Ratio of 0.60. The chart below compares the historical Sharpe Ratios of LCSIX and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

LCSIX vs. CURE - Drawdown Comparison

The maximum LCSIX drawdown since its inception was -25.13%, smaller than the maximum CURE drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for LCSIX and CURE.

Drawdown Indicators

	LCSIX	CURE	Difference
Max Drawdown Largest peak-to-trough decline	-25.13%	-69.19%	+44.06%
Max Drawdown (1Y) Largest decline over 1 year	-3.87%	-31.10%	+27.23%
Max Drawdown (3Y) Largest decline over 3 years	-11.60%	-51.93%	+40.33%
Max Drawdown (5Y) Largest decline over 5 years	-13.21%	-52.23%	+39.02%
Max Drawdown (10Y) Largest decline over 10 years	-13.54%	-69.19%	+55.65%
Current Drawdown Current decline from peak	-9.15%	-26.94%	+17.79%
Average Drawdown Average peak-to-trough decline	-6.37%	-18.16%	+11.79%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.04%	13.71%	-11.67%

Volatility

LCSIX vs. CURE - Volatility Comparison

The current volatility for LoCorr Long/Short Commodity Strategies Fund (LCSIX) is 1.25%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 14.30%. This indicates that LCSIX experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LCSIX	CURE	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.25%	14.30%	-13.05%
Volatility (6M) Calculated over the trailing 6-month period	5.11%	30.87%	-25.76%
Volatility (1Y) Calculated over the trailing 1-year period	6.20%	44.32%	-38.12%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	5.51%	43.84%	-38.33%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	6.67%	49.59%	-42.92%

LCSIX vs. CURE - Expense Ratio Comparison

LCSIX has a 1.75% expense ratio, which is higher than CURE's 1.08% expense ratio.

Dividends

LCSIX vs. CURE - Dividend Comparison

LCSIX's dividend yield for the trailing twelve months is around 2.27%, more than CURE's 1.16% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CURE Direxion Daily Healthcare Bull 3x Shares	1.16%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%	0.00%	0.00%
LCSIX LoCorr Long/Short Commodity Strategies Fund	2.27%	2.32%	2.75%	1.88%	10.75%	7.14%	2.94%	0.54%	12.36%	0.02%	3.21%	7.36%

Frequently Asked Questions

Can I hold both LCSIX and CURE in my portfolio?

LCSIX and CURE have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LCSIX or CURE?

CURE has higher volatility (14.30%) compared to LCSIX (1.25%). In terms of maximum drawdown, LCSIX dropped -25.13% vs CURE's -69.19%.

Which has better risk-adjusted returns?

CURE currently has the higher Sharpe Ratio (0.60 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.